Genetic variance explains poor response to common asthma medications – Medical Xpress


Medical Xpress

Genetic variance explains poor response to common asthma medications
Medical Xpress
Asthma affects close to 26 million people in the United States, 7 million of them children. Although people suffering from asthma share similar clinical symptoms, it is triggered by multiple genetic and environmental factors. This makes asthma a series
Study opens door to new treatment for hard-to-treat asthmatic childrenNews-Medical.net
Why Does Asthma Put a Food-Allergic Child at a Higher Risk of Anaphylaxis?Allergic Living

all 4 news articles »

View full post on asthma – Google News

Public Release: 21-Apr-2015 Genetic variance explains poor response to … – EurekAlert (press release)

Public Release: 21-Apr-2015 Genetic variance explains poor response to
EurekAlert (press release)
CINCINNATI – Researchers have identified a biological basis for asthmatic children who do not respond well to corticosteroid treatment – currently the most effective treatment for chronic asthma and acute asthma attack. Conducted at Cincinnati Children

and more »

View full post on asthma – Google News

Genetic Variance Explains Poor Response to Common Asthma Medications – PR Newswire (press release)

Genetic Variance Explains Poor Response to Common Asthma Medications
PR Newswire (press release)
CINCINNATI, April 21, 2015 /PRNewswire-USNewswire/ — Researchers have identified a biological basis for asthmatic children who do not respond well to corticosteroid treatment – currently the most effective treatment for chronic asthma and acute asthma …

and more »

View full post on asthma – Google News

Comparison of temporal transcriptomic profiles from immature lungs of two rat strains reveals a viral response signature associated with chronic lung dysfunction.

Comparison of temporal transcriptomic profiles from immature lungs of two rat strains reveals a viral response signature associated with chronic lung dysfunction.

PLoS One. 2014;9(12):e112997

Authors: Hines EA, Szakaly RJ, Leng N, Webster AT, Verheyden JM, Lashua AJ, Kendziorski C, Rosenthal LA, Gern JE, Sorkness RL, Sun X, Lemanske RF

Abstract
Early life respiratory viral infections and atopic characteristics are significant risk factors for the development of childhood asthma. It is hypothesized that repeated respiratory viral infections might induce structural remodeling by interfering with the normal process of lung maturation; however, the specific molecular processes that underlie these pathological changes are not understood. To investigate the molecular basis for these changes, we used an established Sendai virus infection model in weanling rats to compare the post-infection transcriptomes of an atopic asthma susceptible strain, Brown Norway, and a non-atopic asthma resistant strain, Fischer 344. Specific to this weanling infection model and not described in adult infection models, Sendai virus in the susceptible, but not the resistant strain, results in morphological abnormalities in distal airways that persist into adulthood. Gene expression data from infected and control lungs across five time points indicated that specific features of the immune response following viral infection were heightened and prolonged in lungs from Brown Norway rats compared with Fischer 344 rats. These features included an increase in macrophage cell number and related gene expression, which then transitioned to an increase in mast cell number and related gene expression. In contrast, infected Fischer F344 lungs exhibited more efficient restoration of the airway epithelial morphology, with transient appearance of basal cell pods near distal airways. Together, these findings indicate that the pronounced macrophage and mast cell responses and abnormal re-epithelialization precede the structural defects that developed and persisted in Brown Norway, but not Fischer 344 lungs.

PMID: 25437859 [PubMed – in process]

View full post on pubmed: asthma